612MO Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study

Autor:	D. Olmos Hidalgo, F. Lopez Campos, M.J. Juan Fita, N. Romero Laorden, Miguel Ramírez-Backhaus, A.M. Gutierrez Pecharromán, Heather Thorne, Judith Balmaña, R. Lozano Mejorada, Shahneen Sandhu, S. Arevalo Lobera, Isabel M. Aragón, I. Chirivella Gonzalez, J. Rubio Briones, Amanda Sanz, Colin C. Pritchard, E. Castro Marcos, Constanza Maximiano Alonso, Urbano Anido, Gemma Llort
Rok vydání:	2020
Předmět:	Prostate cancer Oncology business.industry Somatic cell Cancer research Medicine Hematology business medicine.disease Germline
Zdroj:	Annals of Oncology. 31:S509-S510
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.872
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1fb9cd63282730019610861486c8e6ad https://doi.org/10.1016/j.annonc.2020.08.872 Zobrazit plný text záznamu